Organ-derived dendritic cells have differential effects on alloreactive T cells

Area of Science:

• Immunology
• Transplantation Biology
• Cellular Trafficking

Background:

• Dendritic cells (DCs) play a crucial role in initiating graft-versus-host disease (GVHD) post-bone marrow transplantation (BMT).
• DCs can influence T cell organ-tropism by inducing specific homing molecules.

Purpose of the Study:

• To investigate how organ-derived dendritic cells influence T cell homing and subsequent GVHD.
• To determine if in vitro imprinting of homing molecules correlates with in vivo GVHD outcomes.

Main Methods:

• Adoptive transfer of CFSE-labeled cells in a murine BMT model.
• In vitro priming of naive allogeneic T cells with host-type dendritic cells from various organs (liver, spleen, skin, gut).
• Analysis of T cell homing molecule expression and GVHD mortality/morbidity.

Main Results:

• Alloreactive T cells differentially up-regulated homing molecules in vivo.
• Gut-derived DCs induced T cells with a gut-homing phenotype, leading to higher GVHD mortality and morbidity.
• Liver-derived DCs exhibited reduced stimulatory capacity compared to other organ-derived DCs.
• In vivo homing molecule imprinting was found to be transient.

Conclusions:

• Organ-derived dendritic cells effectively induce specific homing molecules on alloreactive T cells.
• A gut-homing phenotype in T cells correlates with increased GVHD severity after murine BMT.
• The gut plays a significant role in the pathophysiology of GVHD.